Listing 3 - Actual negotiations

Indication:

Crohn's disease

Indication:

Management of heavy menstrual bleeding associated with uterine fibroids

Indication:

For the first-line treatment of adult patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.

Indication:

Patients with Type 1 Diabetes aged 2 years and old

Indication:

Paroxysmal nocturnal hemoglobinuria (PNH)

Indication:

In combination with carboplatin and paclitaxel for the treatment of adult patients with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy.

Indication:

Advanced non-small cell lung cancer, KRAS G12C-mutated

Indication:

For the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).

Indication:

As an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes mellitus, dyslipidemia, or obstructive sleep apnea.

Indication:

For the treatment of metastatic osteosarcoma in patients who received at least 1 prior line of therapy.